8-15 Novavax applied to the FDA for an EUA of NVX-CoV2373 as a booster after a primary series of the vaccine (homologous booster) or any other vaccine (heterologous booster) in adults 18 years of age or older.

8-31 For the first time since the beginning of the pandemic, a majority (58%) of Americans dying from the coronavirus were at least partially vaccinated. The waning efficacy of COVID-19 vaccines and increasingly contagious strains of the virus being spread to elderly and immunocompromised people have resulted in more deaths among those who have taken at least one vaccine dose.